351 related articles for article (PubMed ID: 23099485)
21. Concise review: The evolution of human pluripotent stem cell culture: from feeder cells to synthetic coatings.
Villa-Diaz LG; Ross AM; Lahann J; Krebsbach PH
Stem Cells; 2013 Jan; 31(1):1-7. PubMed ID: 23081828
[TBL] [Abstract][Full Text] [Related]
22. GMP scale-up and banking of pluripotent stem cells for cellular therapy applications.
Ausubel LJ; Lopez PM; Couture LA
Methods Mol Biol; 2011; 767():147-59. PubMed ID: 21822873
[TBL] [Abstract][Full Text] [Related]
23. Feeder-independent culture systems for human pluripotent stem cells.
Moody J
Methods Mol Biol; 2013; 946():507-21. PubMed ID: 23179852
[TBL] [Abstract][Full Text] [Related]
24. Improved generation of patient-specific induced pluripotent stem cells using a chemically-defined and matrigel-based approach.
Groß B; Sgodda M; Rasche M; Schambach A; Göhring G; Schlegelberger B; Greber B; Linden T; Reinhardt D; Cantz T; Klusmann JH
Curr Mol Med; 2013 Jun; 13(5):765-76. PubMed ID: 23642058
[TBL] [Abstract][Full Text] [Related]
25. Autogeneic feeders for the culture of undifferentiated human embryonic stem cells in feeder and feeder-free conditions.
Choo A; Ngo AS; Ding V; Oh S; Kiang LS
Methods Cell Biol; 2008; 86():15-28. PubMed ID: 18442642
[TBL] [Abstract][Full Text] [Related]
26. Cryopreservation of pluripotent stem cell aggregates in defined protein-free formulation.
Sart S; Ma T; Li Y
Biotechnol Prog; 2013; 29(1):143-53. PubMed ID: 23125166
[TBL] [Abstract][Full Text] [Related]
27. Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions.
van den Berg CW; Elliott DA; Braam SR; Mummery CL; Davis RP
Methods Mol Biol; 2016; 1353():163-80. PubMed ID: 25626427
[TBL] [Abstract][Full Text] [Related]
28. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
[TBL] [Abstract][Full Text] [Related]
29. Efficient Differentiation of Postganglionic Sympathetic Neurons using Human Pluripotent Stem Cells under Feeder-free and Chemically Defined Culture Conditions.
Wu HF; Zeltner N
J Vis Exp; 2020 May; (159):. PubMed ID: 32510508
[TBL] [Abstract][Full Text] [Related]
30. Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions.
Hayashi Y; Chan T; Warashina M; Fukuda M; Ariizumi T; Okabayashi K; Takayama N; Otsu M; Eto K; Furue MK; Michiue T; Ohnuma K; Nakauchi H; Asashima M
PLoS One; 2010 Nov; 5(11):e14099. PubMed ID: 21124894
[TBL] [Abstract][Full Text] [Related]
31. Xeno-free culture of human pluripotent stem cells.
Bergström R; Ström S; Holm F; Feki A; Hovatta O
Methods Mol Biol; 2011; 767():125-36. PubMed ID: 21822871
[TBL] [Abstract][Full Text] [Related]
32. Chemically defined and growth-factor-free culture system for the expansion and derivation of human pluripotent stem cells.
Yasuda SY; Ikeda T; Shahsavarani H; Yoshida N; Nayer B; Hino M; Vartak-Sharma N; Suemori H; Hasegawa K
Nat Biomed Eng; 2018 Mar; 2(3):173-182. PubMed ID: 31015717
[TBL] [Abstract][Full Text] [Related]
33. Human-Induced Pluripotent Stem Cell Culture Methods Under cGMP Conditions.
Rivera T; Zhao Y; Ni Y; Wang J
Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e117. PubMed ID: 32649060
[TBL] [Abstract][Full Text] [Related]
34. A cost-effective and efficient reprogramming platform for large-scale production of integration-free human induced pluripotent stem cells in chemically defined culture.
Beers J; Linask KL; Chen JA; Siniscalchi LI; Lin Y; Zheng W; Rao M; Chen G
Sci Rep; 2015 Jun; 5():11319. PubMed ID: 26066579
[TBL] [Abstract][Full Text] [Related]
35. Rapid and efficient generation of neurons from human pluripotent stem cells in a multititre plate format.
Zhang M; Schöler HR; Greber B
J Vis Exp; 2013 Mar; (73):e4335. PubMed ID: 23486189
[TBL] [Abstract][Full Text] [Related]
36. Generation of Cardiomyocytes from Pluripotent Stem Cells.
Nakahama H; Di Pasquale E
Methods Mol Biol; 2016; 1353():181-90. PubMed ID: 25523811
[TBL] [Abstract][Full Text] [Related]
37. Methods for the derivation and use of cardiomyocytes from human pluripotent stem cells.
Zhu WZ; Van Biber B; Laflamme MA
Methods Mol Biol; 2011; 767():419-31. PubMed ID: 21822893
[TBL] [Abstract][Full Text] [Related]
38. A thermoresponsive and chemically defined hydrogel for long-term culture of human embryonic stem cells.
Zhang R; Mjoseng HK; Hoeve MA; Bauer NG; Pells S; Besseling R; Velugotla S; Tourniaire G; Kishen RE; Tsenkina Y; Armit C; Duffy CR; Helfen M; Edenhofer F; de Sousa PA; Bradley M
Nat Commun; 2013; 4():1335. PubMed ID: 23299885
[TBL] [Abstract][Full Text] [Related]
39. Effects of various culture conditions on pluripotent stem cell derivation from chick embryos.
Farzaneh M; Zare M; Hassani SN; Baharvand H
J Cell Biochem; 2018 Aug; 119(8):6325-6336. PubMed ID: 29393549
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
